课题基金 / 基金详情

BLRD Research Career Scientist Award Application

BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
批准号:
10594020
负责人:
Katrin F Chua
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2027-03-31
关键词:
AddressAgeAgingAreaAutomobile DrivingAwardBindingBiochemicalBiochemistryBiological ProcessBiologyBiology of AgingCancer BiologyCardiovascular DiseasesCell AgingCell physiologyCellsChromatinChronic DiseaseCollaborationsDNA DamageDNA SequenceDNA Sequence AlterationDefectDiabetes MellitusDirect CostsDiseaseEnzymesEpigenetic ProcessFunctional disorderFundingFutureGene Expression RegulationGene FamilyGenesGenetic TranscriptionGenomic InstabilityGenomic approachGenomicsGoalsGrantHealthHealthcareHeart DiseasesHeterochromatinHistone DeacetylaseHistone DeacetylationHomeostasisHumanImpairmentInflammationInflammatoryJournalsLeadLinkLiver diseasesLongevityLysineMalignant NeoplasmsMediatingMetabolicMetabolic DiseasesMetabolic stressMetabolismMethylationMolecularMolecular BiologyMorbidity - disease rateMusculoskeletalNatureNeoplasm MetastasisNerve DegenerationNuclearObesityOncogenicOrganismOrphanOxidative StressPaperPathogenicityPathologicPathologyPathway interactionsPhysiologicalPhysiologyPopulationProcessProteinsProteomicsPublishingReaderRegulationResearchResearch ActivityResearch PersonnelResistanceRisk FactorsRoleScientistSignal PathwaySignal TransductionSirtuinsSquamous Cell Lung CarcinomaStressSystemTherapeuticTissuesTranscriptTranslatingUnited States National Institutes of HealthUniversitiesUntranslated RNAVeteransWorkage relatedagedcareerepigenomicsgene networkhistone methyltransferaseimmunosenescenceimprovedin vivoinsightinterestmembermilitary veteranmouse modelmuscle regenerationneoplasticnon-alcoholic fatty liver diseasenovelnovel therapeutic interventionpatient populationpreventprofessorprogramssenescencestem cell biologystructural biologytargeted treatmenttelomeretumor growth

项目摘要

项目成果

Katrin F Chua的其他基金

相似基金

相关文献

中文摘要
翻译
老龄化是许多慢性疾病的最大风险因素,包括癌症、神经退行性变、糖尿病、 和心脏病。目前,大约一半的退伍军人管理局人口年龄在65岁以上,在接下来的十年里, 预计这些退伍军人中将有300多万人超过75岁。因此,研究调节衰老的基因 而与衰老相关的病理对生物医学的进步至关重要,以造福退伍军人 健康。这项研究项目研究了两个这样的基因,SIRT6和SIRT7,它们是主基因 衰老组织中许多变化的“调节器”,如DNA损伤、代谢和氧化应激, 细胞衰老和炎症。我们的项目研究了这些基因的活性如何降低 在心血管和肝脏疾病、糖尿病、肥胖症和许多癌症中的病理作用,以及如何 激活这些基因可以预防这些疾病。通过确定可以作为目标的路径 对于治疗,这项研究可以直接影响退伍军人的健康。 。
英文摘要
Aging is the greatest risk factor for many chronic diseases including cancer, neurodegeneration, diabetes, and heart disease. Currently, roughly half of the VA population is aged 65+ years, and in the next ten years, more than 3 million of these veterans are expected to be over 75. Thus, studying genes that regulate aging and aging-associated pathologies is critically important for biomedical advancements to benefit veterans’ health. This research program investigates two such genes, SIRT6 and SIRT7, which are “master regulators” of many changes in aging tissues, such as DNA damage, metabolic and oxidative stress, cellular senescence, and inflammation. Our projects study how decreased activity of these genes may contribute to pathologies in cardiovascular and liver disease, diabetes, obesity, and many cancers, and how activating these genes could protect against these pathologies. By identifying pathways that can be targeted for therapy, this research can directly impact the health of the Veteran population. .
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Medical Scientist Training Program
  • 批准号:
    10410260
  • 项目类别:
  • 资助金额:
    $182.52万
  • 财政年份:
    2022
  • 负责人:
    Katrin F Chua
  • 依托单位:
Medical Scientist Training Program
  • 批准号:
    10621959
  • 项目类别:
  • 资助金额:
    $197.38万
  • 财政年份:
    2022
  • 负责人:
    Katrin F Chua
  • 依托单位:
Histone Deacetylation Signaling in Aging and Cancer Pathways
Histone Deacetylation Signaling in Aging and Cancer Pathways
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: